Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sqz Biotechnologies Company (NY:SQZ)

N/A UNCHANGED
Last Price Updated: 5:00 PM EDT, Jul 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sqz Biotechnologies Company

< Previous 1 2 3 4 5 Next >
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Committee Votes Against Recommending Approval Of Kidney Disease Drug... 
Via Benzinga
SQZ Biotechnologies Announces Lead Cell Therapy Candidate Induced Radiographic, Symptomatic and Immune Response as Monotherapy in Post-Checkpoint HPV+ Solid Tumor Patient
From SQZ Biotechnologies Company
Via Business Wire
SQZ Biotechnologies' Cell Therapy Shows Favorable Safety Profile In HPV+ Solid Tumors
SQZ Biotechnologies Company (NYSE: SQZ) announced interim results from the highest-dose monotherapy cohort of Phase 1/2 trial of SQZ-PBMC-HPV in Human... 
Via Benzinga
SQZ Biotechnologies Lead Cell Therapy Candidate Generated Monotherapy Clinical Response Correlated with Substantial CD8 T Cell Tumor Infiltration in HPV+ Solid Tumor at Highest Dose
From SQZ Biotechnologies Company
Via Business Wire
SQZ Biotechnologies Announces Acceptance by Roche Accelerator in China
From SQZ Biotechnologies Company
Via Business Wire
SQZ Biotechnologies to Present at the 4th Annual Evercore ISI HealthCONx Conference
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies to Present at the Stifel 2021 Virtual Healthcare Conference
From SQZ Biotechnologies Company
Via Business Wire
SQZ Biotechnologies Presents New AAC, eAPC Platform Research and First Enhanced Tumor Infiltrating Lymphocyte Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies Reports Third Quarter 2021 Financial Results and Recent Portfolio Updates
From SQZ Biotechnologies Company
Via Business Wire
The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M... 
Via Benzinga
SQZ Biotechnologies Announces Independent DSMB Recommendation to Advance Lead Cell Therapy Candidate Into Combination With Checkpoint Inhibitors
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies to Present New Data at the Society for Immunotherapy of Cancer Annual Meeting
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies to Present at the Chardan 5th Annual Genetic Medicines Conference
From SQZ Biotechnologies
Via Business Wire
Illumina Ventures Closes $325 Million Fund Supporting Start-ups in Healthcare Innovation
SOURCE: Illumina 
Via 3BL Media
SQZ Biotechnologies to Present at Cantor Global Healthcare Conference
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies Announces First Autoimmune Disease Indication for Tolerizing Antigen Carrier (TAC) Platform
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies to Present at Upcoming Health Care Conferences
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies Reports Second Quarter 2021 Financial Results and Recent Portfolio Updates
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies Presents Regenerative Medicine Data Demonstrating Neuron Generation from Human Pluripotent Stem Cells with Single Delivery of mRNA Transcription Factor
From SQZ Biotechnologies Company
Via Business Wire
The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) Agios Pharmaceuticals, Inc... 
Via Benzinga
SQZ Biotechnologies' TAC Program Induces Multiple Mechanisms Of Antigen-Specific Tolerance, Animal Study Shows
SQZ Biotechnologies Company (NYSE: SQZ) has announced preclinical results from its Tolerizing Antigen Carrier (TAC) program, showing potential for application in... 
Via Benzinga
SQZ Biotechnologies Tolerizing Antigen Carrier (TAC) Program Induces Antigen-Specific Immune Tolerance in Preclinical Models Demonstrating Potential for Broad Applicability Across Autoimmune Diseases
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies Initial First-In-Human Data Demonstrates Investigational Cell Therapy is Safe and Can Stimulate Immune Responses in Certain Patients with Advanced or Metastatic HPV16+ Tumors
From SQZ Biotechnologies Company
Via Business Wire
SQZ Biotech to Present at Jefferies Virtual Health Care Conference
From SQZ Biotechnologies Company
Via Business Wire
SQZ Biotechnologies to Present First Clinical Data at the American Society of Clinical Oncology Annual Meeting from Ongoing Phase 1 Study in Patients with Advanced or Metastatic HPV+ Tumors
From SQZ Biotechnologies Company
Via Business Wire
SQZ Biotechnologies Reports First Quarter 2021 Financial Results and Recent Business Highlights
From SQZ Biotechnologies Company
Via Business Wire
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
Via Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.